DISCOUNT OPTIONSSCHEIN - FRESENIUS MEDICAL CARE Stock

Certificat

DE000ME063G6

Real-time Bid/Ask 03:03:50 2024-05-24 EDT
0.102 EUR / 0.17 EUR +15.25% Intraday chart for DISCOUNT OPTIONSSCHEIN - FRESENIUS MEDICAL CARE
Current month-5.04%
1 month-28.26%
Date Price Change
24-05-23 0.118 0.00%
24-05-22 0.118 -5.60%
24-05-21 0.125 -2.34%
24-05-20 0.128 -5.19%
24-05-17 0.135 +33.66%

Delayed Quote Börse Stuttgart

Last update May 23, 2024 at 12:39 pm

More quotes

Static data

Product typeExotic Products
Buy / SellCALL
Underlying FRESENIUS MEDICAL CARE AG
Issuer Morgan Stanley
WKN ME063G
ISINDE000ME063G6
Date issued 2023-08-31
Strike 53
Maturity 2024-06-21 (29 Days)
Parity 1 : 1
Emission price 0.82
Emission volume N/A
Settlement cash
Currency EUR

Technical Indicators

Highest since issue 1.14
Lowest since issue 0.096
Spread 0.058
Spread %33.53%

Company Profile

Fresenius Medical Care AG, formerly Fresenius Medical Care AG & Co. KGaA is a Germany-based Company, which is a kidney dialysis institute. The Company provides dialysis care and related services to persons suffering from end-stage renal disease (ESRD), as well as other healthcare services. The Company also develops and manufactures a wide variety of health care products, which includes dialysis and non-dialysis products. Its dialysis products include hemodialysis machines, peritoneal cyclers, dialyzers, peritoneal solutions and granulates, bloodlines, renal pharmaceuticals and systems for water treatment. Its non-dialysis products include acute cardiopulmonary and apheresis products. The Company supplies dialysis clinics it owns, operates or manages with a broad range of products, and sells dialysis products to other dialysis service providers.
Sector
-
More about the company

Ratings for Fresenius Medical Care AG

Trading Rating
Investor Rating
ESG Refinitiv
A-
More Ratings

Consensus: Fresenius Medical Care AG

Sell
Consensus
Buy
Mean consensus
HOLD
Number of Analysts
19
Last Close Price
38.38 EUR
Average target price
39.84 EUR
Spread / Average Target
+3.81%
Consensus